Central Diabetes Insipidus

Research on central diabetes insipidus, a condition caused by deficient production of antidiuretic hormone (ADH/vasopressin) from the hypothalamus or pituitary. Studies evaluate urine output reduction, fluid balance, and quality of life.

Quick Answer

What it is

Research on central diabetes insipidus, a condition caused by deficient production of antidiuretic hormone (ADH/vasopressin) from the hypothalamus or pituitary. Studies evaluate urine output reduction, fluid balance, and quality of life.

Key findings

  • Grade A: Urine Output (Diabetes Insipidus) (Desmopressin (DDAVP))
  • Grade A: Fluid Balance (Desmopressin (DDAVP))

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Central Diabetes Insipidus

  • Supplements Studied:1
1 supps · 2 outcomes

Detailed Outcomes

A
Urine Output (Diabetes Insipidus)
First-line treatment for central diabetes insipidus. Dramatically reduces polyuria and normalizes fluid balance with intranasal or oral administration.
largeImproves
A
Fluid Balance
Restores normal fluid homeostasis in central diabetes insipidus patients, reducing polydipsia and polyuria.
largeImproves

Research Citations (54)

A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
(2025)
PMID: 40723839
Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature.
(2024)
PMID: 37779064
Desmopressin, Misoprostol, nor Carboprost Affect Platelet Aggregability Following Traumatic Brain Injury and Aspirin.
(2024)
PMID: 38359679
Desmopressin use in major cardiac surgery is associated with renal impairment: a retrospective single-center analysis.
(2024)
PMID: 39375596
Safety and efficacy of desmopressin (DDAVP) in preventing hematoma expansion in intracranial hemorrhage associated with antiplatelet drugs use: A systematic review and metaanalysis.
(2024)
PMID: 38778788
Desmopressin (DDAVP) use in patients with von Willebrand disease: A single-centre retrospective review of test response and clinical outcomes.
(2023)
PMID: 37257847
Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in patients with central diabetes insipidus.
(2022)
PMID: 36240057
Desmopressin Stimulates Nitric Oxide Production in Human Lung Microvascular Endothelial Cells.
(2022)
PMID: 35327581
Desmopressin in canine mammary carcinoma: Comments on the importance of the administration route.
(2021)
PMID: 32700352
Safety of renal biopsy bleeding prophylaxis with desmopressin.
(2021)
PMID: 34590925

Related Conditions